// App-Quantinova.ai

e20017 : Salvage therapy for metastatic acral or mucosal melanoma: Efficacy and safety analysis of nab-paclitaxel/carboplatin combined with bevacizumab in c-kit/BRAF wild-type pts.

Researchers

Presenter

  • Chuan Liang Cui

Principal Investigators

  • Si Ming Li

  • Li Li Mao

  • Bin Lian

  • Xuan Wang

  • Bi Xia Tang

  • Jun Guo

  • Lu Si

  • Zhihong Chi

  • Xi Nan Sheng

Medical Centers

  • Peking University Cancer Hospital & Institute, Beijing, China

  • Peking University Cancer Hospital & Institute, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mucosal melanoma

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Circulating tumor cells

Drug/Treatment

  • Bevacizumab

  • Carboplatin

  • Paclitaxel

  • Protein-bound paclitaxel

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved